Rezultati - Ballesteros, Anabel
- Showing 1 - 3 results of 3
-
1
HER2/neu testing for anti-HER2-based therapies in patients with unresectable and/or metastatic gastric cancer od Gómez-Martin, Carlos, Garralda, Elena, Echarri, M José, Ballesteros, Anabel, Arcediano, Alberto, Rodríguez-Peralto, José Luis, Hidalgo, Manuel, López-Ríos, Fernando
Izdano 2012Text -
2
Peripheral Blood Mononuclear Cells Predict Therapeutic Efficacy of Immunotherapy in NSCLC od Rogado, Jacobo, Pozo, Fernando, Troule, Kevin, Sánchez-Torres, José Miguel, Romero-Laorden, Nuria, Mondejar, Rebeca, Donnay, Olga, Ballesteros, Anabel, Pacheco-Barcia, Vilma, Aspa, Javier, Al-Shahrour, Fátima, Alfranca, Arantzazu, Colomer, Ramon
Izdano 2022Text -
3
Dabrafenib plus trametinib for compassionate use in metastatic melanoma: A STROBE-compliant retrospective observational postauthorization study od Martín Algarra, Salvador, Soriano, Virtudes, Fernández-Morales, Luis, Berciano-Guerrero, Miguel-Ángel, Mujika, Karmele, Manzano, José Luis, Puértolas Hernández, Teresa, Soria, Ainara, Rodríguez-Abreu, Delvys, Espinosa Arranz, Enrique, Medina Martínez, Javier, Márquez-Rodas, Ivan, Rubió-Casadevall, Jordi, Ortega, María Eugenia, Jurado García, José Miguel, Lecumberri Biurrun, María José, Palacio, Isabel, Rodríguez de la Borbolla Artacho, María, Altozano, Javier Pérez, Castellón Rubio, Victoria Eugenia, García, Almudena, Luna, Pablo, Ballesteros, Anabel, Fernández, Ovidio, López Martín, Jose Antonio, Berrocal, Alfonso, Arance, Ana
Izdano 2017Text